US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 48.360
  • -0.520-1.06%
Close Mar 31 16:00 ET
  • 48.360
  • 0.0000.00%
Post 18:14 ET
2.97BMarket Cap11.43P/E (TTM)

About Protagonist Therapeutics Company

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Company Profile

SymbolPTGX
Company NameProtagonist Therapeutics
Listing DateAug 11, 2016
Issue Price12.00
Founded2006
CEODr. Dinesh V. Patel, PhD
MarketNASDAQ
Employees126
Fiscal Year Ends12-31
Address7707 Gateway Boulevard,Suite 140
CityNewark
ProvinceCalifornia
CountryUnited States of America
Zip Code94560-1160
Phone1-510-474-0170
Websitehttp://www.protagonist-inc.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Dinesh V. Patel, PhD
  • Director, President and Chief Executive Officer
  • 7.07M
  • Dr. Arturo Molina, M.D.
  • Chief Medical Officer
  • --
  • Asif Ali
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.40M
  • Dr. Suneel Gupta, PhD
  • Executive Vice President, Clinical Development
  • 2.22M
  • Dr. Harold E. Selick, PhD
  • Chairman of the Board
  • 395.27K
  • Sarah A. O’Dowd
  • Independent Director
  • 341.52K
  • William D. Waddill
  • Independent Director
  • 364.02K
  • Bryan Giraudo
  • Independent Director
  • 356.52K
  • Dr. Lewis T. Willia M.D.,PhD
  • Independent Director
  • 351.52K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Precision Drilling
PDS
46.620
Lantheus
LNTH
97.600
eBay
EBAY
67.730
4
DexCom
DXCM
68.290
5
Collegium Pharmaceutical
COLL
29.850
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Earnings Season Underway
Earnings season is here. What to know?